» Articles » PMID: 27594594

Fluorescence-based Measurement of Cystine Uptake Through XCT Shows Requirement for ROS Detoxification in Activated Lymphocytes

Overview
Publisher Elsevier
Date 2016 Sep 6
PMID 27594594
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

T and B lymphocytes undergo metabolic re-programming upon activation that is essential to allow bioenergetics, cell survival, and intermediates for cell proliferation and function. To support changes in the activity of signaling pathways and to provide sufficient and necessary intracellular metabolites, uptake of extracellular nutrients increases sharply with metabolic re-programming. One result of increased metabolic activity can be reactive oxygen species (ROS), which can be toxic when accumulated in excess. Uptake of cystine allows accumulation of cysteine that is necessary for glutathione synthesis and ROS detoxification. Cystine uptake is required for T cell activation and function but measurements based on radioactive labeling do not allow analysis on single cell level. Here we show the critical role for cystine uptake in T cells using a method for measurement of cystine uptake using a novel CystineFITC probe. T cell receptor stimulation lead to upregulation of the cystine transporter xCT (SLC7a11) and increased cystine uptake in CD4+ and CD8+ human T cells. Similarly, lipopolysaccharide stimulation increased cystine uptake in human B cells. The CystineFITC probe was not toxic and could be metabolized to prevent cystine starvation induced cell death. Furthermore, blockade of xCT or competition with natural cystine decreased uptake of CystineFITC. CystineFITC is thus a versatile tool that allows measurement of cystine uptake on single cell level and shows the critical role for cystine uptake for T cell ROS regulation and activation.

Citing Articles

Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy.

Nicolini A, Ferrari P Front Immunol. 2024; 15:1353787.

PMID: 39119332 PMC: 11306065. DOI: 10.3389/fimmu.2024.1353787.


The immunosuppressive landscape in tumor microenvironment.

Liu W, Zhou H, Lai W, Hu C, Xu R, Gu P Immunol Res. 2024; 72(4):566-582.

PMID: 38691319 DOI: 10.1007/s12026-024-09483-8.


A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle.

Wang B, Pei J, Xu S, Liu J, Yu J J Exp Clin Cancer Res. 2024; 43(1):74.

PMID: 38459595 PMC: 10921613. DOI: 10.1186/s13046-024-02994-0.


Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment.

Hua Y, Yang S, Zhang Y, Li J, Wang M, Yeerkenbieke P J Exp Clin Cancer Res. 2024; 43(1):19.

PMID: 38217037 PMC: 10787430. DOI: 10.1186/s13046-023-02925-5.


Nutrient inputs and social metabolic control of T cell fate.

Bacigalupa Z, Landis M, Rathmell J Cell Metab. 2023; 36(1):10-20.

PMID: 38118440 PMC: 10872404. DOI: 10.1016/j.cmet.2023.12.009.


References
1.
Vene R, Delfino L, Castellani P, Balza E, Bertolotti M, Sitia R . Redox remodeling allows and controls B-cell activation and differentiation. Antioxid Redox Signal. 2010; 13(8):1145-55. DOI: 10.1089/ars.2009.3078. View

2.
Narang V, Pauletti G, Gout P, Buckley D, Buckley A . Suppression of cystine uptake by sulfasalazine inhibits proliferation of human mammary carcinoma cells. Anticancer Res. 2004; 23(6C):4571-9. View

3.
Garg S, Yan Z, Vitvitsky V, Banerjee R . Differential dependence on cysteine from transsulfuration versus transport during T cell activation. Antioxid Redox Signal. 2010; 15(1):39-47. PMC: 3110100. DOI: 10.1089/ars.2010.3496. View

4.
Lu S . Regulation of glutathione synthesis. Mol Aspects Med. 2008; 30(1-2):42-59. PMC: 2704241. DOI: 10.1016/j.mam.2008.05.005. View

5.
Lewerenz J, Hewett S, Huang Y, Lambros M, Gout P, Kalivas P . The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal. 2012; 18(5):522-55. PMC: 3545354. DOI: 10.1089/ars.2011.4391. View